AULT MILTON C III sold 2K shares of ALZAMEND NEURO, INC. on the open market
Open‑market sale worth $3.1K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/31/2026ACC: 0001214659-26-011121
-2K
Net shares
Net seller
$3.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2K
Price / share
$1.56
Trade value
$3.12K
% of position
New position
8/26/2026
2K→0.00
Total
Net shares
−2K
Net value
-$3.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/26/2026 | S · Sale | −2K | $1.56 | $3.12K | New position | 2K | 0.00 |
| Total | −2K | -$3.12K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned116.65K
Common Stock
IndirectShares owned61.00
Common Stock
IndirectShares owned11.07K
Total
127.78K indirect127.78K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 116.65K | Indirect |
| Common Stock | 61.00 | Indirect |
| Common Stock | 11.07K | Indirect |
| Total | 127.78K | 127.78K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported